BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 25550531)

  • 21. CIITA-induced MHC class II expression in mammary adenocarcinoma leads to a Th1 polarization of the tumor microenvironment, tumor rejection, and specific antitumor memory.
    Mortara L; Castellani P; Meazza R; Tosi G; De Lerma Barbaro A; Procopio FA; Comes A; Zardi L; Ferrini S; Accolla RS
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3435-43. PubMed ID: 16740768
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Two newly diagnosed HLA class II-deficient patients identified by rapid vector-based complementation analysis reveal discoordinate invariant chain expression levels.
    Schmetterer KG; Seidel MG; Körmöczi U; Rottal A; Schwarz K; Matthes-Martin S; Steinberger P; Pickl WF
    Int Arch Allergy Immunol; 2010; 152(4):390-400. PubMed ID: 20197681
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Active suppression of the class II transactivator-encoding AIR-1 locus is responsible for the lack of major histocompatibility complex class II gene expression observed during differentiation from B cells to plasma cells.
    Sartoris S; Tosi G; De Lerma Barbaro A; Cestari T; Accolla RS
    Eur J Immunol; 1996 Oct; 26(10):2456-60. PubMed ID: 8898960
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HLA class II expression in uninducible hepatocarcinoma cells after transfection of AIR-1 gene product CIITA: acquisition of antigen processing and presentation capacity.
    Sartoris S; Valle MT; Barbaro AL; Tosi G; Cestari T; D'Agostino A; Megiovanni AM; Manca F; Accolla RS
    J Immunol; 1998 Jul; 161(2):814-20. PubMed ID: 9670958
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional disruption of human leukocyte antigen II in human embryonic stem cell.
    Chen H; Li Y; Lin X; Cui D; Cui C; Li H; Xiao L
    Biol Res; 2015 Oct; 48():59. PubMed ID: 26506955
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Absence of MHC class II antigen expression in trophoblast cells results from a lack of class II transactivator (CIITA) gene expression.
    Murphy SP; Tomasi TB
    Mol Reprod Dev; 1998 Sep; 51(1):1-12. PubMed ID: 9712312
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The expression and significance of major histocompatibility complex II transactivator gene in five human malignant hematological cell lines].
    You Y; Zou P; Guo R
    Zhonghua Nei Ke Za Zhi; 2004 Apr; 43(4):288-91. PubMed ID: 15130416
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The MHC class II transactivator (CIITA) mRNA stability is critical for the HLA class II gene expression in myelomonocytic cells.
    De Lerma Barbaro A; Procopio FA; Mortara L; Tosi G; Accolla RS
    Eur J Immunol; 2005 Feb; 35(2):603-11. PubMed ID: 15627980
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Class II transactivator-independent endothelial cell MHC class II gene activation induced by lymphocyte adhesion.
    Collinge M; Pardi R; Bender JR
    J Immunol; 1998 Aug; 161(4):1589-93. PubMed ID: 9712019
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MHC class II transactivator represses human IL-4 gene transcription by interruption of promoter binding with CBP/p300, STAT6 and NFAT1 via histone hypoacetylation.
    Zhou X; Jiang Y; Lu L; Ding Q; Jiao Z; Zhou Y; Xin L; Chou KY
    Immunology; 2007 Dec; 122(4):476-85. PubMed ID: 17645498
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Down-regulation of MHC class II expression through inhibition of CIITA transcription by lytic transactivator Zta during Epstein-Barr virus reactivation.
    Li D; Qian L; Chen C; Shi M; Yu M; Hu M; Song L; Shen B; Guo N
    J Immunol; 2009 Feb; 182(4):1799-809. PubMed ID: 19201831
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lack of class II transactivator causes severe deficiency of HLA-DR expression in small cell lung cancer.
    Yazawa T; Kamma H; Fujiwara M; Matsui M; Horiguchi H; Satoh H; Fujimoto M; Yokoyama K; Ogata T
    J Pathol; 1999 Jan; 187(2):191-9. PubMed ID: 10365094
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alterations in CIITA constitute a common mechanism accounting for downregulation of MHC class II expression in diffuse large B-cell lymphoma (DLBCL).
    Cycon KA; Rimsza LM; Murphy SP
    Exp Hematol; 2009 Feb; 37(2):184-194. PubMed ID: 19081173
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CIITA-dependent and -independent class II MHC expression revealed by a dominant negative mutant.
    Zhou H; Su HS; Zhang X; Douhan J; Glimcher LH
    J Immunol; 1997 May; 158(10):4741-9. PubMed ID: 9144488
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Histone acetylation regulates the cell type specific CIITA promoters, MHC class II expression and antigen presentation in tumor cells.
    Chou SD; Khan AN; Magner WJ; Tomasi TB
    Int Immunol; 2005 Nov; 17(11):1483-94. PubMed ID: 16210330
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Highly polarized HLA class II antigen processing and presentation by human intestinal epithelial cells.
    Hershberg RM; Cho DH; Youakim A; Bradley MB; Lee JS; Framson PE; Nepom GT
    J Clin Invest; 1998 Aug; 102(4):792-803. PubMed ID: 9710448
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathologic expression of MHC class II is driven by mitogen-activated protein kinases.
    Martins I; Deshayes F; Baton F; Forget A; Ciechomska I; Sylla K; Aoudjit F; Charron D; Al-Daccak R; Alcaide-Loridan C
    Eur J Immunol; 2007 Mar; 37(3):788-97. PubMed ID: 17304627
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Major histocompatibility class II HLA-DR alpha gene expression in thyrocytes: counter regulation by the class II transactivator and the thyroid Y box protein.
    Montani V; Taniguchi SI; Shong M; Suzuki K; Ohmori M; Giuliani C; Napolitano G; Saji M; Fiorentino B; Reimold AM; Ting JP; Kohn LD; Singer DS
    Endocrinology; 1998 Jan; 139(1):280-9. PubMed ID: 9421426
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A CD4+, HLA-DR7-restricted T-helper lymphocyte clone recognizes an antigen shared by human malignant melanoma and glioma.
    Somasundaram R; Swoboda R; Caputo L; Lee A; Jackson N; Marincola FM; Guerry D; Herlyn D
    Int J Cancer; 2003 Apr; 104(3):362-8. PubMed ID: 12569560
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Invariant chain+ N2a neuroblastoma cells stably expressing the class II MHC transactivator CIITA fail to stimulate anti-tumor immunity.
    Rickard S; Ono SJ
    Exp Mol Pathol; 2008 Dec; 85(3):147-54. PubMed ID: 18952077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.